JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 2 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.45B |
| 3 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.34B |
| 4 |
EA
Electronic Arts
EA
|
+$903M |
| 5 |
Automatic Data Processing
ADP
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.63B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.06B |
| 3 |
Meta Platforms (Facebook)
META
|
+$942M |
| 4 |
Nike
NKE
|
+$779M |
| 5 |
Union Pacific
UNP
|
+$543M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.17% |
| 2 | Technology | 12.62% |
| 3 | Healthcare | 10.37% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGI
3076
CALL
Somnigroup International
SGI
$13.5B
| $2.79M | ﹤0.01% |
+210,800
| New | +$2.81M |
|
3077
CytomX Therapeutics
CTMX
$760M
| $2.79M | ﹤0.01% |
150,584
+10,653
| +8% | +$243K |
|
|
LJPC
3078
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $2.79M | ﹤0.01% |
138,417
+8,388
| +6% | +$219K |
|
|
ESL
3079
DELISTED
Esterline Technologies
ESL
| $2.78M | ﹤0.01% |
30,604
-14,323
| -32% | -$1.21M |
|
3080
NovaGold Resources
NG
$3.45B
| $2.78M | ﹤0.01% |
750,220
-218,683
| -23% | -$882K |
|
|
BEAT
3081
DELISTED
BioTelemetry, Inc.
BEAT
| $2.78M | ﹤0.01% |
43,166
-15,680
| -27% | -$875K |
|
3082
PUT
Macy's
M
$6.26B
| $2.78M | ﹤0.01% |
80,000
-70,000
| -47% | -$2.6M |
|
3083
CryoPort
CYRX
$766M
| $2.77M | ﹤0.01% |
216,523
+57,154
| +36% | +$816K |
|
|
DFRG
3084
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $2.77M | ﹤0.01% |
334,202
+324,604
| +3,382% | +$3.23M |
|
|
CNCE
3085
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $2.77M | ﹤0.01% |
186,831
+34,920
| +23% | +$549K |
|
|
TRK
3086
DELISTED
Speedway Motorsports, Inc.
TRK
| $2.77M | ﹤0.01% |
155,153
+3,111
| +2% | +$54.8K |
|
|
ORIG
3087
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
| $2.77M | ﹤0.01% |
79,945
-259,260
| -76% | -$7.48M |
|
|
LUMO
3088
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $2.77M | ﹤0.01% |
128,541
+76,850
| +149% | +$2.34M |
|
3089
VanEck Agribusiness ETF
MOO
$972M
| $2.76M | ﹤0.01% |
42,055
-117
| -0.3% | -$7.46K |
|
3090
Invesco S&P 500 Top 50 ETF
XLG
$11B
| $2.76M | ﹤0.01% |
132,050
+7,810
| +6% | +$159K |
|
3091
CALL
Evergy
EVRG
$19.2B
| $2.75M | ﹤0.01% |
+50,000
| New | +$2.83M |
|
|
CDR
3092
DELISTED
Cedar Realty Trust, Inc
CDR
| $2.74M | ﹤0.01% |
89,066
-15,366
| -15% | -$472K |
|
3093
iShares US Medical Devices ETF
IHI
$3.48B
| $2.74M | ﹤0.01% |
72,222
+2,502
| +4% | +$88.9K |
|
3094
Aclaris Therapeutics
ACRS
$860M
| $2.73M | ﹤0.01% |
188,380
+4,351
| +2% | +$74.6K |
|
|
LLEX
3095
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
| $2.73M | ﹤0.01% |
558,113
+549,081
| +6,079% | +$2.76M |
|
3096
Healthcare Services Group
HCSG
$1.43B
| $2.73M | ﹤0.01% |
67,230
+3,918
| +6% | +$163K |
|
|
RDS.A
3097
CALL
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $2.73M | ﹤0.01% |
40,000
+5,500
| +16% | +$367K |
|
3098
Surgery Partners
SGRY
$2.01B
| $2.72M | ﹤0.01% |
164,837
-67,519
| -29% | -$1.08M |
|
|
DPLO
3099
CALL
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $2.72M | ﹤0.01% |
+140,000
| New | +$2.98M |
|
3100
CALL
NetEase
NTES
$78.5B
| $2.72M | ﹤0.01% |
59,500
| – | – |
|
Similar funds
JP Morgan Chase's Q3 2018 Portfolio in Review
As of Q3 2018, JP Morgan Chase held 6,019 positions worth $522B, up 7.4% from $486B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2018 filing shows 449 new, 2,597 increased, 2,100 reduced and 313 closed positions. Its largest new stake was JPMorgan BetaBuilders Canada ETF: 29,437,708 shares worth $1.45B. The largest sale was Broadcom, an estimated $1.63B.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q3 2018 buy was JPMorgan BetaBuilders Canada ETF: 29,437,708 shares worth $1.45B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Japan ETF in Q3 2018, an estimated $1.83B increase.
- JP Morgan Chase's biggest Q3 2018 reduction was Broadcom, cutting an estimated $1.63B.
- JP Morgan Chase fully exited Cavium, Inc. in Q3 2018, selling an estimated $316M.
- JP Morgan Chase's ten largest holdings make up 18% of its $522B portfolio in Q3 2018.
- JP Morgan Chase opened 449 new positions and closed 313 in Q3 2018.
- JP Morgan Chase's portfolio value rose 7.4% quarter-over-quarter to $522B.
Based on JP Morgan Chase's 13F filing for Q3 2018, filed 7 Nov 2018.